Literature DB >> 23568465

On exploring structure-activity relationships.

Rajarshi Guha1.   

Abstract

Understanding structure-activity relationships (SARs) for a givenpan> set of molecules allows onpan>e to rationpan>ally explore chemical space anpan>d develop a chemical series optimizinpan>g multiple physicochemical anpan>d biological properties simultanpan>eously, for inpan>stanpan>ce, improvinpan>g potenpan>cy, reducinpan>g pan> class="Disease">toxicity, and ensuring sufficient bioavailability. In silico methods allow rapid and efficient characterization of SARs and facilitate building a variety of models to capture and encode one or more SARs, which can then be used to predict activities for new molecules. By coupling these methods with in silico modifications of structures, one can easily prioritize large screening decks or even generate new compounds de novo and ascertain whether they belong to the SAR being studied. Computational methods can provide a guide for the experienced user by integrating and summarizing large amounts of preexisting data to suggest useful structural modifications. This chapter highlights the different types of SAR modeling methods and how they support the task of exploring chemical space to elucidate and optimize SARs in a drug discovery setting. In addition to considering modeling algorithms, I briefly discuss how to use databases as a source of SAR data to inform and enhance the exploration of SAR trends. I also review common modeling techniques that are used to encode SARs, recent work in the area of structure-activity landscapes, the role of SAR databases, and alternative approaches to exploring SAR data that do not involve explicit model development.

Entities:  

Mesh:

Year:  2013        PMID: 23568465      PMCID: PMC4852705          DOI: 10.1007/978-1-62703-342-8_6

Source DB:  PubMed          Journal:  Methods Mol Biol        ISSN: 1064-3745


  46 in total

1.  The signature molecular descriptor. 1. Using extended valence sequences in QSAR and QSPR studies.

Authors:  Jean-Loup Faulon; Donald P Visco; Ramdas S Pophale
Journal:  J Chem Inf Comput Sci       Date:  2003 May-Jun

2.  An approach to determining applicability domains for QSAR group contribution models: an analysis of SRC KOWWIN.

Authors:  Nina Nikolova-Jeliazkova; Joanna Jaworska
Journal:  Altern Lab Anim       Date:  2005-10       Impact factor: 1.303

3.  On outliers and activity cliffs--why QSAR often disappoints.

Authors:  Gerald M Maggiora
Journal:  J Chem Inf Model       Date:  2006 Jul-Aug       Impact factor: 4.956

4.  SAR index: quantifying the nature of structure-activity relationships.

Authors:  Lisa Peltason; Jürgen Bajorath
Journal:  J Med Chem       Date:  2007-09-29       Impact factor: 7.446

5.  Structure--activity landscape index: identifying and quantifying activity cliffs.

Authors:  Rajarshi Guha; John H Van Drie
Journal:  J Chem Inf Model       Date:  2008-02-28       Impact factor: 4.956

6.  970 million druglike small molecules for virtual screening in the chemical universe database GDB-13.

Authors:  Lorenz C Blum; Jean-Louis Reymond
Journal:  J Am Chem Soc       Date:  2009-07-01       Impact factor: 15.419

7.  Interactive exploration of chemical space with Scaffold Hunter.

Authors:  Stefan Wetzel; Karsten Klein; Steffen Renner; Daniel Rauh; Tudor I Oprea; Petra Mutzel; Herbert Waldmann
Journal:  Nat Chem Biol       Date:  2009-06-28       Impact factor: 15.040

8.  On the interpretation and interpretability of quantitative structure-activity relationship models.

Authors:  Rajarshi Guha
Journal:  J Comput Aided Mol Des       Date:  2008-09-11       Impact factor: 3.686

9.  Statistically validated QSARs, based on theoretical descriptors, for modeling aquatic toxicity of organic chemicals in Pimephales promelas (fathead minnow).

Authors:  Ester Papa; Fulvio Villa; Paola Gramatica
Journal:  J Chem Inf Model       Date:  2005 Sep-Oct       Impact factor: 4.956

10.  Synthesis and SAR studies of chiral non-racemic dexoxadrol analogues as uncompetitive NMDA receptor antagonists.

Authors:  Ashutosh Banerjee; Dirk Schepmann; Jens Köhler; Ernst-Ulrich Würthwein; Bernhard Wünsch
Journal:  Bioorg Med Chem       Date:  2010-09-25       Impact factor: 3.641

View more
  20 in total

1.  Computational maturation of a single-domain antibody against Aβ42 aggregation.

Authors:  Jiacheng Lin; Chiara Figazzolo; Michael A Metrick; Pietro Sormanni; Michele Vendruscolo
Journal:  Chem Sci       Date:  2021-10-07       Impact factor: 9.825

2.  Design, synthesis, and structure activity relationship analysis of new betulinic acid derivatives as potent HIV inhibitors.

Authors:  Yu Zhao; Chin-Ho Chen; Susan L Morris-Natschke; Kuo-Hsiung Lee
Journal:  Eur J Med Chem       Date:  2021-02-14       Impact factor: 6.514

Review 3.  Marine natural products as breast cancer resistance protein inhibitors.

Authors:  Lilia Cherigo; Dioxelis Lopez; Sergio Martinez-Luis
Journal:  Mar Drugs       Date:  2015-04-03       Impact factor: 5.118

4.  Multi-objective optimization of tumor response to drug release from vasculature-bound nanoparticles.

Authors:  Ibrahim M Chamseddine; Hermann B Frieboes; Michael Kokkolaras
Journal:  Sci Rep       Date:  2020-05-19       Impact factor: 4.379

Review 5.  Microfluidic-Based Multi-Organ Platforms for Drug Discovery.

Authors:  Ahmad Rezaei Kolahchi; Nima Khadem Mohtaram; Hassan Pezeshgi Modarres; Mohammad Hossein Mohammadi; Armin Geraili; Parya Jafari; Mohsen Akbari; Amir Sanati-Nezhad
Journal:  Micromachines (Basel)       Date:  2016-09-08       Impact factor: 2.891

6.  Structure Related Inhibition of Enzyme Systems in Cholinesterases and BACE1 In Vitro by Naturally Occurring Naphthopyrone and Its Glycosides Isolated from Cassia obtusifolia.

Authors:  Srijan Shrestha; Su Hui Seong; Pradeep Paudel; Hyun Ah Jung; Jae Sue Choi
Journal:  Molecules       Date:  2017-12-28       Impact factor: 4.411

7.  Prediction on the inhibition ratio of pyrrolidine derivatives on matrix metalloproteinase based on gene expression programming.

Authors:  Yuqin Li; Guirong You; Baoxiu Jia; Hongzong Si; Xiaojun Yao
Journal:  Biomed Res Int       Date:  2014-05-22       Impact factor: 3.411

8.  A VersaTile-driven platform for rapid hit-to-lead development of engineered lysins.

Authors:  H Gerstmans; D Grimon; D Gutiérrez; C Lood; A Rodríguez; V van Noort; J Lammertyn; R Lavigne; Y Briers
Journal:  Sci Adv       Date:  2020-06-03       Impact factor: 14.136

Review 9.  Hierarchical virtual screening approaches in small molecule drug discovery.

Authors:  Ashutosh Kumar; Kam Y J Zhang
Journal:  Methods       Date:  2014-07-27       Impact factor: 3.608

10.  Structure-Activity Relationships and Molecular Docking Analysis of Mcl-1 Targeting Renieramycin T Analogues in Patient-derived Lung Cancer Cells.

Authors:  Korrakod Petsri; Masashi Yokoya; Sucharat Tungsukruthai; Thanyada Rungrotmongkol; Bodee Nutho; Chanida Vinayanuwattikun; Naoki Saito; Matsubara Takehiro; Ryo Sato; Pithi Chanvorachote
Journal:  Cancers (Basel)       Date:  2020-04-03       Impact factor: 6.639

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.